United States Anesthesia Drugs Market worth more than 3 Billion by 2018

ROSWELL, Ga. - June 4, 2015 - PRLog -- United States Anesthesia Drugs Market- Key Facts Covered

•General intravenous anesthesia drugs market is dominating the United States anesthesia drugs market

•      In the United States anesthesia drugs market, Endo Health Solution is the clear leader in 2013

•      Baxter is the only company to offer all three of the most commonly used modern inhaled anesthetics for general anesthesia

•      Local anesthesia drugs market in United States more than US$ 700 Million in 2013

•      Pentobarbital is one of the most common injectable general anesthetic agents used in rodents.

•      Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributor intravenous anesthetic drugs in the United States anesthesia drugs market

•      Lidocane and Articane are top two leading local anesthetic agents in the United States local anesthetic drugs market

Table of Contents:

1. Executive Summary

2. United States Anesthesia Drugs Market (2010 – 2018)

3. United States Anesthesia Drugs Market Share & Forecast (2010 – 2018)

3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2010 – 2018)

3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2010 – 2018)

3.3 United States Local Anesthesia Drugs Market Share & Forecast (2010 – 2018)

3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2010 – 2018)

4. By Type – United States Anesthesia Drugs Market (2008 – 2018)

4.1 United States General Inhalation Anesthesia Drugs Market (2008 – 2018)

4.2 United States General Intravenous Anesthesia Drugs Market (2008 – 2018)

4.3 United States Local Anesthesia Drugs Market (2008 – 2018)

5. By Drugs – United States General Intravenous Anesthesia Drugs Market (2010 – 2018)

5.1 United States Propofol Market (2010 – 2018)

5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2010 – 2018)

5.3 United States Fospropofol Disodium Market (2010 – 2018)

5.4 United States Ketamine Market (2010 – 2018)

5.5 United States Methohexital Sodium Market (2010 – 2018)

5.6 United States Pentobarbital Market (2010 – 2018)

5.7 United States Etomidate Market (2010 – 2018)

5.8 United States Fentanyl Market (2010 – 2018)

6. By Drugs – United States Local Anesthesia Drugs Market (2008 – 2018)

6.1 United States Articaine Market (2008 – 2018)

6.2 United States Bupivacaine Market (2008 – 2018)

6.3 United States Lidocaine Market (2008 – 2018)

6.4 United States Mepivacaine Market (2008 – 2018)

6.5 United States Prilocaine Market (2008 – 2018)

7. Key Players Profile in United States Anesthesia Drugs Market

7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)

7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)

7.3 Abbott Laboratories Anesthesia Drugs Sales & Forecast (2008 – 2018)

7.4 AstraZeneca Anesthetic Drugs Sales (2009 – 2011)

8. United States Anesthesia Drugs Market – Growth Driver

8.1 Increasing Demand for Anesthesia Service

8.2 Increasing Ageing Population and Prevalence of Cardiovascular Disease in United States

8.2.1 Increasing Ageing Population

9. United States Anesthesia Drugs Market – Challenges

9.1 Shortage of Anesthesia Providers in United States

9.2 Shortage of Anesthesia Drugs in United States

Contact Us

Rajat Gupta

Sr. Manager

Sales & Marketing Div

Renub Research

Email: rajat.gupta@renub.com

Phone:  +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India)

Web: http://www.renub.com